New combo therapy shows promise for Drug-Resistant lung cancer
NCT ID NCT03133546
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding bevacizumab to osimertinib helps people with advanced non-small cell lung cancer that has a specific genetic change (EGFR and T790M mutations). 155 adults who had already tried other treatments took part. The main goal was to see if the combination delayed cancer growth better than osimertinib alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
-
Fund. Jimenez Diaz
Madrid, Spain
-
Geneva University Hospital (HUG)
Geneva, Switzerland
-
Hospital Arnau de Vilanova
Valencia, Spain
-
Hospital General Alicante
Alicante, Spain
-
Hospital General de Valencia
Valencia, Spain
-
Hospital Puerta de Hierro
Madrid, Spain
-
Hospital Sant Pau
Barcelona, Spain
-
Hospital Teresa Herrara
A Coruña, Spain
-
Hospital Virgen del Rocio
Seville, Spain
-
Hospital de la Princesa
Madrid, Spain
-
Hospital la Paz
Madrid, Spain
-
ICO Badalona
Barcelona, Spain
-
ICO Hospitalet
Barcelona, Spain
-
Kantonsspital St. Gallen
Sankt Gallen, Switzerland
-
Kantonsspital Winterthur
Winterthur, Switzerland
-
Mid Western Cancer Centre
Limerick, Ireland
-
National Cancer Centre
Goyang, South Korea
-
National University Hospital
Singapore, Singapore
-
OSI Bilbao Basurto
Bilbao, Spain
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
-
St. James Hospital
Dublin, Ireland
-
Tan Tock Seng Hospital
Singapore, Singapore
-
UniversitatSpital Zurich
Zurich, Switzerland
-
VU University Medical Centre
Amsterdam, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple-drug cocktail re-sensitize lung cancer to treatment?
- Could a lung cancer drug designed for one mutation work for another?
- Could chemo plus immunotherapy double the punch against tough lung cancers?
- Should all advanced lung cancer patients get a brain scan? new trial aims to find out
- New hope for tough lung cancer? trial tests targeted drug against chemo
- New combo therapy for lung cancer under Real-World watch